TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Q-linea AB ( (SE:QLINEA) ).
Q-linea AB has increased its total number of shares and votes to 18,949,081 as of November 28, 2025, following a rights issue and a directed issue of shares. This expansion in share capital is a strategic move to strengthen the company’s financial position, potentially enhancing its market presence and operational capabilities in the healthcare sector.
The most recent analyst rating on (SE:QLINEA) stock is a Sell with a SEK23.00 price target. To see the full list of analyst forecasts on Q-linea AB stock, see the SE:QLINEA Stock Forecast page.
More about Q-linea AB
Q-linea is a company specializing in rapid antimicrobial susceptibility testing systems, particularly their ASTar® system, which aids hospitals in quickly identifying optimal treatments for bloodstream infections and sepsis. The company is based in Uppsala, Sweden, and operates globally with regional offices in Italy and the USA.
Average Trading Volume: 13,368
Technical Sentiment Signal: Sell
Current Market Cap: SEK454.6M
Learn more about QLINEA stock on TipRanks’ Stock Analysis page.